cannabis/nicotine

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH N/A FIELD OF THE INVENTION The present invention relates to tobacco products such as cigarettes, cigars, pipe tobacco (bulk), roll your own, and smokeless tobacco products also known as "snuff," "chewing tobacco," and "dipping tobacco." More

The present invention relates to a novel use of an antagonist of the central cannabinoid receptors, known as the CB1 receptors. More particularly, the invention relates to the use of a CB1-receptor antagonist for the preparation of medicinal products that are useful for helping to quit tobacco

FIELD OF THE INVENTION The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB.sub.1 cannabinoid receptor. Preferably the cannabinoid is

BACKGROUND OF THE INVENTION Marijuana (Cannabis sativa L.) and its derivatives have been used for centuries for medicinal and recreational purposes. A major active ingredient in marijuana and hashish has been determined to be .DELTA.9-tetrahydrocannabinol (.DELTA.9-THC). Detailed research has

SUMMARY OF THE INVENTION The present invention is concerned with substituted imidazole of the general Formula I: ##STR00001## and pharmaceutically acceptable salts thereof which are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention

SUMMARY OF THE INVENTION The present invention is concerned with substituted imidazole of the general Formula I: ##STR00001## and pharmaceutically acceptable salts thereof which are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention